Drug Profile
CO 101244
Alternative Names: PD 174494Latest Information Update: 23 Dec 1998
Price :
$50
*
At a glance
- Originator Pfizer; Purdue Pharma
- Class Antiparkinsonians; Neuroprotectants
- Mechanism of Action NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Parkinson's disease
Most Recent Events
- 23 Dec 1998 New profile
- 23 Dec 1998 Discontinued-Preclinical for Parkinson's disease in USA (Unknown route)